Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $808.67, a high ...

Guangzhou Pharmaceutical Holdings Limited (GPHL), a Fortune Global 500 company, has taken a significant step forward in its ...

After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers ...

We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest’s Substack. In ...

Hedge funds revealed their top investment ideas, from Chinese self-driving taxis to an Indian drug retailer, at the annual ...

Initial results show a 17x increase in processing speed using NVIDIA H100 GPUs on NVIDIA DGX CloudParis, France – June xx 2025 – Cure51, the Techbio company on a mission to decode the biology of ...

Alvotech and Advanz Pharma previously entered into partnership agreements, signed in 2023, to commercialize proposed biosimilars to Xolair® (omalizumab), Simponi® (golimumab), Entyvio® (vedolizumab), ...

CRL and CHDI Foundation extend their Huntington's disease partnership, boosting integration and global flexibility in drug discovery.

Shares of Pfizer have fallen about 62% from their COVID-19 pandemic highs. The stock is way down, but the company has raised ...

Asia-Pacific markets were set to open mostly higher Wednesday after Wall Street rose on the back of a tech rally, led by ...

Regeneron Pharmaceuticals, Inc. REGN is looking to make inroads in the lucrative obesity market. The company recently entered ...